Purine analogues in the management of lymphoproliferative diseases
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Clinical Oncology
- Vol. 8 (5) , 289-296
- https://doi.org/10.1016/s0936-6555(05)80714-9
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Transfusion‐associated graft‐versus‐host disease in fludarabine‐treated B‐chronic lymphocytic leukaemiaBritish Journal of Haematology, 1994
- Kinetics of Recovery of CD4+ T Cells in Peripheral Blood of Deoxycoformycin-Treated PatientsJNCI Journal of the National Cancer Institute, 1991
- Pentostatin (2′-deoxycoformycin) for the treatment of lymphoid neoplasmsCancer Treatment Reviews, 1990
- Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of CancerJNCI Journal of the National Cancer Institute, 1990
- Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- 2′ deoxycoformycin (pentostatin) for refractory non‐Hodgkin's lymphoma: A calgb phase II studyMedical and Pediatric Oncology, 1990
- Cytotoxic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine 5-monophosphate (fludarabine, NSC 312887) in a human tumor cloning systemEuropean Journal of Cancer and Clinical Oncology, 1988
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980